Status | Study |
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition: Adult Fibrosarcoma Alveolar Soft Part Sarcoma Angiomatoid Date: 2014-07-01 Interventions: Drug: Doxorubicin Hydrochloride |
Active, not recruiting |
Study Name: SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) Condition: Malignant Peripheral Nerve Sheath Tumors (MPNST) Sarcoma Date: 2013-11-25 Interventions: Drug: ganetespib 200 mg/m² |
Active, not recruiting |
Study Name: SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors Condition: Malignant Peripheral Nerve Sheath Tumors MPNST Date: 2012-08-07 Interventions: Drug: everolimus 10 mg tablet |
Active, not recruiting |
Study Name: Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Condition: Myxofibrosarcoma Recurrent Adult Soft Tissue Sarcoma Recur Date: 2012-07-26 Interventions: Drug: Alisertib Given PO |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2012-02-06 Interventions: Drug: Gemcitabine Hydrochloride |
Terminated |
Study Name: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) Condition: Sarcoma Leiomyosarcoma Malignant Per Date: 2011-08-15 Interventions: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib |
Recruiting |
Study Name: Natural History Study of Patients With Neurofibromatosis Type I Condition: Neurofibromatosis Type 1 Malignant Peripheral Nerve Sheath Tumor Date: 2009-06-17 |
Recruiting |
Study Name: HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Condition: Rhabdomyosarcoma Osteosarcoma Ewing Sarcoma Date: 2009-05-28 Interventions: Biological: HSV1716 |
Completed |
Study Name: Sorafenib and Dacarbazine in Soft Tissue Sarcoma Condition: Sarcoma Synovial Sarcoma Leiomyosarcoma Date: 2009-02-04 Interventions: Drug: Sorafenib and Dacarbazine Treatment will be administ |
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition: Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Date: 2008-07-19 Interventions: Biological: Cixutumumab Given |